Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAST2 mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | Mast2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAST2 mRNA | CTD | PMID:36331819 | (S)-nicotine | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | Nicotine results in increased expression of MAST2 mRNA | CTD | PMID:33640489 | 1,2-dimethylhydrazine | decreases expression | ISO | Mast2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of MAST2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Mast2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAST2 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of MAST2 mRNA | CTD | PMID:26865667 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mast2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MAST2 mRNA | CTD | PMID:21570461 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of MAST2 mRNA | CTD | PMID:21346803 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | MAST2 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAST2 gene | CTD | PMID:31601247 | all-trans-retinoic acid | decreases expression | ISO | MAST2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MAST2 mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | ISO | MAST2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of MAST2 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | ISO | MAST2 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of MAST2 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MAST2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | MAST2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MAST2 intron | CTD | PMID:30157460 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of MAST2 mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | MAST2 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of MAST2 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | Mast2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MAST2 mRNA | CTD | PMID:38074096 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MAST2 mRNA | CTD | PMID:30816183 and PMID:33296240 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MAST2 protein | CTD | PMID:24552547 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of MAST2 mRNA | CTD | PMID:19167457 | caffeine | affects phosphorylation | ISO | MAST2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of MAST2 protein | CTD | PMID:35688186 | carbon nanotube | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of MAST2 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | MAST2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MAST2 gene] | CTD | PMID:28238834 | copper atom | multiple interactions | ISO | Mast2 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAST2 mRNA | CTD | PMID:15467011 | copper(0) | multiple interactions | ISO | Mast2 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAST2 mRNA | CTD | PMID:15467011 | copper(II) sulfate | decreases expression | ISO | MAST2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MAST2 mRNA | CTD | PMID:19549813 | coumarin | affects phosphorylation | ISO | MAST2 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of MAST2 protein | CTD | PMID:35688186 | dibutyl phthalate | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of MAST2 mRNA | CTD | PMID:21266533 | dicrotophos | increases expression | ISO | MAST2 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of MAST2 mRNA | CTD | PMID:28302478 | ethanol | affects expression | ISO | Mast2 (Mus musculus) | 6480464 | Ethanol affects the expression of MAST2 mRNA | CTD | PMID:30319688 | fenthion | decreases expression | ISO | Mast2 (Mus musculus) | 6480464 | Fenthion results in decreased expression of MAST2 mRNA | CTD | PMID:34813904 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of MAST2 mRNA | CTD | PMID:30307764 | folic acid | multiple interactions | ISO | Mast2 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAST2 mRNA | CTD | PMID:22206623 | FR900359 | decreases phosphorylation | ISO | MAST2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of MAST2 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | MAST2 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAST2 gene | CTD | PMID:31601247 | genistein | increases expression | ISO | MAST2 (Homo sapiens) | 6480464 | Genistein results in increased expression of MAST2 mRNA | CTD | PMID:26865667 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MAST2 mRNA | CTD | PMID:22061828 | glycidol | decreases expression | EXP | | 6480464 | glycidol results in decreased expression of MAST2 mRNA | CTD | PMID:24915197 | lead diacetate | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | lead acetate results in increased expression of MAST2 mRNA | CTD | PMID:21829687 | methamphetamine | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of MAST2 mRNA | CTD | PMID:26307267 | methidathion | decreases expression | ISO | Mast2 (Mus musculus) | 6480464 | methidathion results in decreased expression of MAST2 mRNA | CTD | PMID:34813904 | nicotine | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | Nicotine results in increased expression of MAST2 mRNA | CTD | PMID:33640489 | Nivalenol | decreases expression | ISO | Mast2 (Mus musculus) | 6480464 | nivalenol results in decreased expression of MAST2 mRNA | CTD | PMID:35016910 | ozone | multiple interactions | ISO | Mast2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAST2 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | Mast2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MAST2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | MAST2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of MAST2 mRNA | CTD | PMID:29067470 | pentachlorophenol | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of MAST2 mRNA | CTD | PMID:23892564 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mast2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAST2 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | Mast2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of MAST2 mRNA | CTD | PMID:23091169 | pirinixic acid | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of MAST2 mRNA | CTD | PMID:23811191 | quercetin | decreases phosphorylation | ISO | MAST2 (Homo sapiens) | 6480464 | Quercetin results in decreased phosphorylation of MAST2 protein | CTD | PMID:35688186 | testosterone | decreases expression | ISO | Mast2 (Mus musculus) | 6480464 | Testosterone deficiency results in decreased expression of MAST2 mRNA | CTD | PMID:33848595 | testosterone | multiple interactions | ISO | Mast2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:33848595 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAST2 mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | Mast2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of MAST2 mRNA | CTD | PMID:31919559 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of MAST2 mRNA | CTD | PMID:31150632 | triptonide | affects expression | ISO | Mast2 (Mus musculus) | 6480464 | triptonide affects the expression of MAST2 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | ISO | Mast2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of MAST2 mRNA | CTD | PMID:30912803 | valproic acid | affects expression | ISO | Mast2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of MAST2 mRNA | CTD | PMID:17292431 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of MAST2 mRNA | CTD | PMID:29427782 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
